EDGE PharmaTech: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
EDGE PharmaTech
Largest movements
- Receivables within one year +€20,964
up €20,964 (+77.8%), from €26,948 to €47,912
of which Trade receivables: +€20,962
- Cash -€4,260
down €4,260 (-8.4%), from €50,913 to €46,653
mainly Contributions, distributions and other (-€60,000) and Receivables within one year (-€20,964)
- Tangible fixed assets -€1,165
down €1,165 (-45.4%), from €2,563 to €1,398
- Other debts +€23,868
up €23,868 (+59.3%), from €40,266 to €64,134
- Tax, wage and social debts -€15,663
down €15,663 (-44.7%), from €35,000 to €19,338
of which Taxes: -€15,641
- Trade debts +€4,602
up €4,602 (+2908.3%), from €158 to €4,760
- Profit (loss) carried forward +€2,813
new in 2025: €2,813
- Gross operating margin +€32,815
up €32,815 (+66.5%), from €49,375 to €82,190
- Taxes +€6,354
up €6,354 (+56.2%), from €11,312 to €17,666
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €80,424 | €96,045 | +€15,621 | +19.4% |
| Fixed assets | 21/28 | €2,563 | €1,398 | -€1,165 | -45.4% |
| Tangible fixed assets | 22/27 | €2,563 | €1,398 | -€1,165 | -45.4% |
| Furniture and vehicles | 24 | €2,563 | €1,398 | -€1,165 | -45.4% |
| Current assets | 29/58 | €77,861 | €94,647 | +€16,786 | +21.6% |
| Amounts receivable within one year | 40/41 | €26,948 | €47,912 | +€20,964 | +77.8% |
| Trade receivables | 40 | €26,947 | €47,909 | +€20,962 | +77.8% |
| Other amounts receivable | 41 | €2 | €4 | +€2 | +100.0% |
| Cash at bank and in hand | 54/58 | €50,913 | €46,653 | -€4,260 | -8.4% |
| Deferred charges and accrued income | 490/1 | - | €82 | +€82 | |
| Total equity and liabilities | 10/49 | €80,424 | €96,045 | +€15,621 | +19.4% |
| Equity | 10/15 | €5,000 | €7,813 | +€2,813 | +56.3% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | - | €2,813 | +€2,813 | |
| Amounts payable | 17/49 | €75,424 | €88,232 | +€12,808 | +17.0% |
| Amounts payable within one year | 42/48 | €75,424 | €88,232 | +€12,808 | +17.0% |
| Trade debts | 44 | €158 | €4,760 | +€4,602 | +2908.3% |
| Suppliers | 440/4 | €158 | €4,760 | +€4,602 | +2908.3% |
| Taxes, remuneration and social security | 45 | €35,000 | €19,338 | -€15,663 | -44.7% |
| Taxes | 450/3 | €33,280 | €17,640 | -€15,641 | -47.0% |
| Remuneration and social security | 454/9 | €1,720 | €1,698 | -€22 | -1.3% |
| Other amounts payable | 47/48 | €40,266 | €64,134 | +€23,868 | +59.3% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,438 | €1,165 | -€273 | -19.0% |
| Other operating charges | 640/8 | €64 | €229 | +€165 | +258.8% |
| Gross operating margin | 9900 | €49,375 | €82,190 | +€32,815 | +66.5% |
| Operating profit (loss) | 9901 | €47,873 | €80,796 | +€32,923 | +68.8% |
| Financial income | 75/76B | €0 | €0 | = | 0.0% |
| Recurring financial income | 75 | €0 | €0 | = | 0.0% |
| Financial charges | 65/66B | €372 | €316 | -€55 | -14.9% |
| Recurring financial charges | 65 | €372 | €316 | -€55 | -14.9% |
| Profit (loss) for the period before taxes | 9903 | €47,501 | €80,479 | +€32,978 | +69.4% |
| Income taxes | 67/77 | €11,312 | €17,666 | +€6,354 | +56.2% |
| Profit (loss) for the period | 9904 | €36,189 | €62,813 | +€26,624 | +73.6% |
| Profit (loss) for the period to be appropriated | 9905 | €36,189 | €62,813 | +€26,624 | +73.6% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 9 October 2026 via checked.be.